Article Details
Retrieved on: 2025-04-08 19:28:37
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses peripheral edema, a common side effect when combining savolitinib and osimertinib to treat EGFR-mutant non-small cell lung cancer, highlighting the relevance to tags such as lung cancer and osimertinib.
Article found on: www.oncologynurseadvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here